Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

Total article views   HTML views PDF downloads Totals
15,498 Dovepress* 9,684+ 2,273 11,957
PubMed Central* 5,814 648 6,462
Totals 15,498 2,921 18,419
*Since 22 June 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar